Aurobindo Pharma To Buy Parts Of Sandoz US
The Swiss drugmaker, Novartis AG, said in a statement to the press that it would sell the dermatology and generic US oral solids portfolios of...
Tag : Aurobindo Pharma
Aurobindo Pharma to acquire Apotex operations in 5 European countries
Aurobindo Pharma has signed definitive agreement to acquire from Apotex International Inc, its commercial operations and certain supporting infrastructure in five European countries, for 74 million euros....
Aurobindo Pharma gets USFDA approval for Azithromycin tablets
Aurobindo Pharma has received final approval to manufacture and market Azithromycin tablets, from the USFDA. The tablets are used for the treatment of patients with mild...
Aurobindo Pharma gets USFDA approval to market Ibuprofen capsules
Aurobindo Pharma has received final approval to manufacture and market Ibuprofen capsules. The approval has been received from the US health regulator. In a BSE filing the...
Aurobindo Pharma receives USFDA nod for Ertapenem injection
Aurobindo Pharma has received USFDA’s go ahead, for Ertapenem injection. Ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz injection and the...
Aurobindo Pharma receives 9 observations from USFDA
Aurobindo Pharma has received 9 Form 483 observations from USFDA, for its Unit IV injectable facility. Unit IV is situated in Pashamailaram near Hyderabad, where it...
Aurobindo receives USFDA approval for Fondaparinux Sodium injection
The US health regulator has given approval to Aurobindo Pharma, for manufacturing and marketing generic version of Fondaparinux Sodium injection, which is used to prevent deep vein...
Aurobindo Pharma receives USFDA approval to market kidney ailment drug
Aurobindo Pharma has got the final approval from the USDFA for manufacturing and marketing Sevelamer Carbonate tablets in the American market. Aurobindo Pharma has said...
Aurobindo Pharma receives 6 observations from USFDA for its Unit-3 plant in Hyderabad
On Wednesday, Aurobindo Pharma has said that it has received a Form 483 with six observations from United States Food and Drug Administration (US FDA)...
Aurobindo Pharma has received USFDA final approval
The US Food and Drug Administration has provided its final approval to the Aurobindo Pharma Ltd for manufacturing Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30...